Lenci I - Search Results

1

Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre- to post-liver transplant: a real-life strategy.

Donato MF, Morelli C, Romagnoli R, Invernizzi F, Mazzarelli C, Iemmolo RM, Montalbano M, Lenci I, Bhoori S, Pieri G, Berardi S, Caraceni P, Martini S; ITACOPS-SOF Bridging Study Group. Donato MF, et al. Among authors: lenci i. Liver Int. 2017 May;37(5):678-683. doi: 10.1111/liv.13322. Epub 2016 Dec 26. Liver Int. 2017. PMID: 27865034 Free article.

2

A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C.

Angelico M, Petrolati A, Lionetti R, Lenci I, Burra P, Donato MF, Merli M, Strazzabosco M, Tisone G. Angelico M, et al. Among authors: lenci i. J Hepatol. 2007 Jun;46(6):1009-17. doi: 10.1016/j.jhep.2006.12.017. Epub 2007 Feb 5. J Hepatol. 2007. PMID: 17328985 Clinical Trial.

3

Maintenance ribavirin monotherapy delays fibrosis progression in liver transplant recipients with recurrent hepatitis C at high risk of progression.

Lionetti R, Tisone G, Palmieri G, Almerighi C, Anselmo A, Tariciotti L, Lenci I, De Luca L, Monaco A, Angelico M. Lionetti R, et al. Among authors: lenci i. Dig Liver Dis. 2010 Apr;42(4):297-303. doi: 10.1016/j.dld.2009.08.008. Epub 2009 Oct 8. Dig Liver Dis. 2010. PMID: 19818696

4

Total and covalently closed circular DNA detection in liver tissue of long-term survivors transplanted for HBV-related cirrhosis.

Lenci I, Marcuccilli F, Tisone G, Di Paolo D, Tariciotti L, Ciotti M, Guenci T, Perno CF, Angelico M. Lenci I, et al. Dig Liver Dis. 2010 Aug;42(8):578-84. doi: 10.1016/j.dld.2009.12.003. Epub 2010 Jan 22. Dig Liver Dis. 2010. PMID: 20097143

5

Safety of complete and sustained prophylaxis withdrawal in patients liver-transplanted for HBV-related cirrhosis at low risk of HBV recurrence.

Lenci I, Tisone G, Di Paolo D, Marcuccilli F, Tariciotti L, Ciotti M, Svicher V, Perno CF, Angelico M. Lenci I, et al. J Hepatol. 2011 Sep;55(3):587-593. doi: 10.1016/j.jhep.2010.12.036. Epub 2011 Jan 18. J Hepatol. 2011. PMID: 21251938

6

Vitamin D3 modulates T lymphocyte responses in hepatitis C virus-infected liver transplant recipients.

Almerighi C, Bergamini A, Lionetti R, Sinistro A, Lenci I, Tariciotti L, Tisone G, Angelico M. Almerighi C, et al. Among authors: lenci i. Dig Liver Dis. 2012 Jan;44(1):67-73. doi: 10.1016/j.dld.2011.08.010. Epub 2011 Sep 17. Dig Liver Dis. 2012. PMID: 21930443

7

Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study.

Angelico M, Nardi A, Marianelli T, Caccamo L, Romagnoli R, Tisone G, Pinna AD, Avolio AW, Fagiuoli S, Burra P, Strazzabosco M, Costa AN; Liver Match Investigators. Angelico M, et al. J Hepatol. 2013 Apr;58(4):715-23. doi: 10.1016/j.jhep.2012.11.025. Epub 2012 Nov 28. J Hepatol. 2013. PMID: 23201239

8

Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: potent antiviral activity but no clinical benefit if treatment is given late.

Pellicelli AM, Montalbano M, Lionetti R, Durand C, Ferenci P, D'Offizi G, Knop V, Telese A, Lenci I, Andreoli A, Zeuzem S, Angelico M. Pellicelli AM, et al. Among authors: lenci i. Dig Liver Dis. 2014 Oct;46(10):923-7. doi: 10.1016/j.dld.2014.06.004. Epub 2014 Jul 3. Dig Liver Dis. 2014. PMID: 24997638 Clinical Trial.

9

Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome.

Cento V, Di Paolo D, Di Carlo D, Micheli V, Tontodonati M, De Leonardis F, Aragri M, Antonucci FP, Di Maio VC, Mancon A, Lenci I, Manunta A, Taliani G, Di Biagio A, Nicolini LA, Nosotti L, Sarrecchia C, Siciliano M, Landonio S, Pellicelli A, Gasbarrini A, Vecchiet J, Magni CF, Babudieri S, Mura MS, Andreoni M, Parruti G, Rizzardini G, Angelico M, Perno CF, Ceccherini-Silberstein F. Cento V, et al. Among authors: lenci i. Dig Liver Dis. 2015 Feb;47(2):157-63. doi: 10.1016/j.dld.2014.11.010. Epub 2014 Nov 24. Dig Liver Dis. 2015. PMID: 25544656 Free article.

10

Standard bowel cleansing is highly ineffective in cirrhotic patients undergoing screening colonoscopy.

Salso A, De Leonardis F, Lionetti R, Lenci I, Angelico M, Telese A, Baiocchi L. Salso A, et al. Among authors: lenci i. Dig Liver Dis. 2015 Jun;47(6):523-5. doi: 10.1016/j.dld.2015.02.013. Epub 2015 Mar 6. Dig Liver Dis. 2015. PMID: 25819557

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

119 results

Search Page